Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2022 ∙ Bencina, G. Fues Wahl, H. Tsoumani, E. Salomonsson, S.
Recommendations and Health Technology Assessment (HTA) landscape evaluation for pediatric pneumococcal conjugate vaccines (PCV) in Europe: a systematic literature review
Europe Children Pneumococcal disease Economic aspects Administration
Rating:
Not applicable
2022 ∙ Nweze, K. Hart-Pinto, A. Philip, L. Mortimer, K. Whitehead, K. A. Shokrollahi, K.
Recommendations for Influenza Vaccination in Burns Patients Based on a Systematic Review of the Evidence
All age groups Influenza Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Mardiyan Kurniawati, E. Rahmawati, N. A.
Records of antibodies in breast milk in postpartum women who have been vaccinated or exposed to COVID-19: A systematic review
Parents/caregivers COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Puig-Barbera, J. Tamames-Gomez, S. Plans-Rubio, P. Eiros-Bouza, J. M.
Relative Effectiveness of Cell-Cultured versus Egg-Based Seasonal Influenza Vaccines in Preventing Influenza-Related Outcomes in Subjects 18 Years Old or Older: A Systematic Review and Meta-Analysis
Adults Older adults Influenza Efficacy/effectiveness
Rating:
High
2022 ∙ Zhang, J. Cao, J. Ye, Q.
Renal Side Effects of COVID-19 Vaccination
Adolescents Adults Older adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Lane, S. Yeomans, A. Shakir, S.
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature
Adolescents Adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Parker, E. P. K. Desai, S. Marti, M. Nohynek, H. Kaslow, D. C. Kochhar, S. O'Brien, K. L. Hombach, J. Wilder-Smith, A.
Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review
Adults Older adults COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Kroon, F. P. B. Najm, A. Alunno, A. Schoones, J. W. Landewe, R. B. M. Machado, P. M. Navarro-Compan, V.
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations
All age groups COVID-19 Safety Efficacy/effectiveness
Rating:
Low
2022 ∙ Tsiorou, K. Sarantaki, A.
Risk Assessment of COVID-19 Vaccination Among Childbearing Women
Adults Adolescents Pregnant women COVID-19 Safety Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Petrá M Janovská, D. Čelko, A. M. D Selinger, E. Dole Neradov Franklová, M. Dlouhý, P. Rosina, J. Lesná, I. K.
Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression
All age groups COVID-19 Efficacy/effectiveness
Rating:
Low
Loading...